Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about NVS
Recent news which mentions NVS
< Previous
1
2
...
17
18
19
20
21
22
23
24
Next >
The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More
April 12, 2022
Tickers
AGLE
ALPN
ATNM
BDSX
Tags
Movers
GRCL
AGLE
From
Benzinga
Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?
April 12, 2022
Tickers
ABBV
AMGN
CANF
NVS
Tags
Market News
NVS
CANF
From
Benzinga
Overview Of Value Stocks In The Healthcare Sector
April 11, 2022
Tickers
CO
DYNT
NVS
OVID
Tags
Market News
NVS
DYNT
From
Benzinga
The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More
April 10, 2022
Tickers
AGLE
ALPN
BCYC
BTAI
Tags
LLY
TVTX
NVS
From
Benzinga
3 Things About Pfizer That Smart Investors Know
April 08, 2022
Tickers
ABBV
AZN
BMY
GSK
Tags
PFE
RHHB/F
SNY
From
Motley Fool
Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks
April 08, 2022
Tickers
BIIB
BLUE
GILD
IBB
Tags
NASDAQ:BLUE,NASDAQ:IBB,NYSEARCA:XBI,NASDAQ:MRNA,,NYSE:NVS,NASDAQ:GILD,NYSE:MRK,NASDAQ:BIIB,NYSE:PFE
XBI
PFE
From
InvestorPlace
Novartis' Breast Cancer PI3K Drug, Scores FDA Approval For Ultra-Rare Indication
April 06, 2022
Tickers
NVS
Tags
NVS
Market News
FDA
From
Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
April 06, 2022
Tickers
BGNE
BTAI
CCCC
CTXR
Tags
SRRK
INCY
MRK
From
Benzinga
Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis
April 05, 2022
Tickers
NVS
Tags
NVS
Market News
General
From
Benzinga
The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel
April 05, 2022
Tickers
ACAD
ARGX
ATRA
BMY
Tags
Market News
NVS
SAGE
From
Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
Tickers
ABBV
ALNY
AMGN
APTX
Tags
ALNY
CHRS
SPY
From
InvestorPlace
Morning Brief: Top Stories Dominating Financial Media on Monday, April 4
April 04, 2022
Tickers
AAPL
CRRFY
FRCOY
MMM
Tags
TWTR
SBUX
FRCOY
From
Benzinga
Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure
April 04, 2022
Tickers
NVS
Tags
Briefs
Benzinga
Biotech
From
Benzinga
3 CEOs to Invest In
April 01, 2022
Tickers
ANTM
AXSM
AZN
GH
Tags
JAZZ
GH
IMCR
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
April 01, 2022
Tickers
ABBV
AKBA
ALNY
AMRX
Tags
Market News
NVS
RHHBY
From
Benzinga
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
Tickers
ACMR
AMGN
BABA
BGNE
Tags
ZLAB
BABA
ACMR
From
InvestorPlace
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
March 27, 2022
Tickers
ADMP
AFIB
AFMD
AGRX
Tags
Penny Stocks
AMPE
ALDX
From
Benzinga
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
March 27, 2022
Tickers
AZN
GRFS
GSK
JNJ
Tags
NVS
Market News
MRNA
From
Motley Fool
Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD
March 25, 2022
Tickers
NVS
Tags
Benzinga
Health Care
Biotech
From
Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
March 24, 2022
Tickers
INCY
NVO
NVS
Tags
Recent Press Releases
NVS
Market News
From
Motley Fool
This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants
March 24, 2022
Tickers
AMGN
CANF
NVS
Tags
Can/Fite BioPharma Ltd/
Biotech
Benzinga
From
Benzinga
FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer
March 24, 2022
Tickers
NVS
Tags
General
FDA
NVS
From
Benzinga
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
March 24, 2022
Tickers
AHPA
APLS
ASND
ATHA
Tags
DGX
IMMP
TFFP
From
Benzinga
This Company Is Making Progress In Its Fight Against Rare, Terminal Cancers
March 22, 2022
Tickers
FUSN
LNTH
NVS
PNT
Tags
Penny Stocks
YMAB
FUSN
From
Benzinga
The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout
March 22, 2022
Tickers
ADMP
AGTC
ANAB
APTO
Tags
ORIC
MRK
ANAB
From
Benzinga
Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22
March 22, 2022
Tickers
BABA
BYDDY
CP
FB
Tags
Benzinga
GS
XPEV
From
Benzinga
Novartis Suspends Some Investment, Business Activities In Russia
March 22, 2022
Tickers
NVS
Tags
News
Russia/Ukraine War
Briefs
From
Benzinga
This group of stocks is flagging a rebound, and that’s good news for the S&P 500, says technical analyst
March 22, 2022
Tickers
AAPL
AMC
AZN
BABA
Tags
NIO
TSLA
ES00
From
MarketWatch
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
March 19, 2022
Tickers
NVS
PFE
VYGR
Tags
PFE
VYGR
Market News
From
Motley Fool
2 Top Stocks to Buy in March and Hold Forever
March 15, 2022
Tickers
NVS
RHHBY
VIVO
Tags
VIVO
Market News
Recent Press Releases
From
Motley Fool
< Previous
1
2
...
17
18
19
20
21
22
23
24
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.